TeraGanix, Inc – Trademark Portfolio
Entity Type: 03
TeraGanix, Inc holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AG1000 and DR. DON'S. The owner is based in Alto, TX.
14193 US HWY 69 S
Alto, TX 75925
Showing of trademarks Trademarks
Trademark Classifications
TeraGanix, Inc's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TeraGanix, Inc have?
TeraGanix, Inc has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 cancelled.
What trademark classes does TeraGanix, Inc file in?
TeraGanix, Inc files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are TeraGanix, Inc's most well-known trademarks?
TeraGanix, Inc's registered trademark portfolio includes well-known marks such as AG1000 and DR. DON'S. These are among 2 currently registered trademarks in the portfolio.
What is TeraGanix, Inc's trademark registration success rate?
TeraGanix, Inc has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.